First results from a screening of 300 naturally occurring compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 3,4,6-tribromo-2-(2′,4′-dibromophenoxy)phenol and 5-epi-Nakijinone Q as substances with the potential for anticancer therapy

被引:0
|
作者
Mayer, S. [1 ]
Prechtl, M. [1 ]
Liebfried, P. [2 ]
Cadeddu, R. -P. [2 ]
Stuhldreier, F. [3 ]
Wenzel, F. [1 ]
Stork, B. [3 ]
Wesselborg, S. [3 ]
Proksch, P. [4 ]
Germing, U. [2 ]
Haas, R. [2 ]
Jaeger, P. [2 ]
机构
[1] Hsch Furtwangen Univ, Fak Med & Life Sci, Villingen Schwenningen, Germany
[2] Univ Klinikum Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany
[3] Univ Klinikum Dusseldorf, Inst Mol Med 1, Dusseldorf, Germany
[4] Heinrich Heine Univ Dusseldorf, Inst Pharmazeut Biol & Biotechnol, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P771
引用
收藏
页码:217 / 217
页数:1
相关论文
共 3 条
  • [1] First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2′,4′-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy
    Mayer, Saskia
    Prechtl, Marie
    Liebfried, Pia
    Cadeddu, Ron-Patrick
    Stuhldreier, Fabian
    Kohl, Matthias
    Wenzel, Folker
    Stork, Bjoern
    Wesselborg, Sebastian
    Proksch, Peter
    Germing, Ulrich
    Haas, Rainer
    Jaeger, Paul
    MARINE DRUGS, 2019, 17 (09)
  • [2] 4,6-Dibromo-2-[(E)-(4-{[(E)-3,5-dibromo2-hydroxybenzylidene]amino}butyl)iminomethyl]phenol
    Kargar, Hadi
    Kia, Reza
    Ardakania, Amir Adabi
    Tahir, Muhammad Nawaz
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2270 - +
  • [3] 2-(4′,4′-dimethyl-3′,4′-dihydrooxazol-2′-yl)phenol:: Some first-row transition metal complexes of this naturally occurring binding group
    Mugesh, G
    Singh, HB
    Butcher, RJ
    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2001, (03) : 669 - 678